Emerson Erik C. (CIK 1710496) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-20). Recent activity: Buy APUS (750,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | Apimeds Pharmaceuticals US, Inc. (APUS) | Chief Executive Officer | Buy | 750,000 | $0 |
Source: SEC Form 4 filings · as of 2025-05-20